EP1451218A4 - Procedes utiles dans le traitement et le pronostic de la leucemie et d'autres types de cancer - Google Patents

Procedes utiles dans le traitement et le pronostic de la leucemie et d'autres types de cancer

Info

Publication number
EP1451218A4
EP1451218A4 EP02760520A EP02760520A EP1451218A4 EP 1451218 A4 EP1451218 A4 EP 1451218A4 EP 02760520 A EP02760520 A EP 02760520A EP 02760520 A EP02760520 A EP 02760520A EP 1451218 A4 EP1451218 A4 EP 1451218A4
Authority
EP
European Patent Office
Prior art keywords
prognosis
leukemia
treatment
methods
cancer types
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02760520A
Other languages
German (de)
English (en)
Other versions
EP1451218A2 (fr
Inventor
Sarit Larisch
Ronit Elhasid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fund For Medical Research Development Of Infrastructure & Health Services Rambam Medical Center
FUND FOR MEDICAL RES DEV OF IN
Original Assignee
Fund For Medical Research Development Of Infrastructure & Health Services Rambam Medical Center
FUND FOR MEDICAL RES DEV OF IN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fund For Medical Research Development Of Infrastructure & Health Services Rambam Medical Center, FUND FOR MEDICAL RES DEV OF IN filed Critical Fund For Medical Research Development Of Infrastructure & Health Services Rambam Medical Center
Publication of EP1451218A2 publication Critical patent/EP1451218A2/fr
Publication of EP1451218A4 publication Critical patent/EP1451218A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP02760520A 2001-08-07 2002-08-07 Procedes utiles dans le traitement et le pronostic de la leucemie et d'autres types de cancer Withdrawn EP1451218A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31025601P 2001-08-07 2001-08-07
US310256P 2001-08-07
PCT/IL2002/000649 WO2003013422A2 (fr) 2001-08-07 2002-08-07 Procedes utiles dans le traitement et le pronostic de la leucemie et d'autres types de cancer

Publications (2)

Publication Number Publication Date
EP1451218A2 EP1451218A2 (fr) 2004-09-01
EP1451218A4 true EP1451218A4 (fr) 2006-03-08

Family

ID=23201665

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02760520A Withdrawn EP1451218A4 (fr) 2001-08-07 2002-08-07 Procedes utiles dans le traitement et le pronostic de la leucemie et d'autres types de cancer

Country Status (4)

Country Link
EP (1) EP1451218A4 (fr)
CA (1) CA2456909A1 (fr)
IL (1) IL160242A0 (fr)
WO (1) WO2003013422A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005211232A1 (en) * 2004-01-07 2005-08-18 Rambam Medical Center, Funds For Medical Research Development Of Infrastructure And Health Services Induction of apoptosis via ARTS-IAP complexes
US20150018285A1 (en) 2012-02-15 2015-01-15 Carmel-Haifa University Economic Corporation Ltd. ANTAGONISTS OF Bcl-2 AND USES THEREOF IN INDUCTION OF APOPTOSIS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3141107B2 (ja) * 1998-11-16 2001-03-05 工業技術院長 ヒト由来ブラディオン蛋白質、それをコードするｄｎａ及びそれらの使用
AU2001231141A1 (en) * 2000-01-29 2001-08-07 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Novel human septin and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LARISCH S ET AL: "A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif", NATURE CELL BIOLOGY, MACMILLAN PUBLISHERS, GB, vol. 2, December 2000 (2000-12-01), pages 915 - 921, XP000926564, ISSN: 1465-7392 *

Also Published As

Publication number Publication date
CA2456909A1 (fr) 2003-02-20
WO2003013422A3 (fr) 2004-05-21
IL160242A0 (en) 2004-07-25
WO2003013422A2 (fr) 2003-02-20
EP1451218A2 (fr) 2004-09-01

Similar Documents

Publication Publication Date Title
IL251270A0 (en) Cancer treatment
EG24356A (en) Antitumor compounds and methods
AU6147401A (en) Compositions and methods for the treatment of cancer
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
AU2002331290A1 (en) Methods for the treatment of cancer with irinotecan based on cyp3a5
EP1442062A4 (fr) Methodes de traitement du carcinome
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
EP1476067A4 (fr) Compositions et procedes contre le cancer
EP1509539A4 (fr) Compositions et procedes concernant le cancer
GB2389532C (en) The method of treating cancer
PL368035A1 (en) Compositions and methods for the treatment of cancer
EP1469769A4 (fr) Nouvelles compositions et methodes contre le cancer
MXPA03007036A (es) Metodo de terapia para cancer.
EP1401377A4 (fr) Methodes de traitement du cancer
AU2003223538A1 (en) Methods for the treatment of cancer
EP1469870A4 (fr) Nouvelles compositions et methodes pour le traitement du cancer
AU2002366195A8 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2002327643A1 (en) Detection and treatment of cancers of the liver
IL160242A0 (en) Methods for the treatment and prognosis of leukemia and other cancer types
AU2002304883A1 (en) Device for the treatment of tumours
AU2004281077A1 (en) Methods and agents for the treatment of cancer
AU2002305138A1 (en) Methods and materials for cancer treatment
AU2002360454A8 (en) Methods and compositions for treating cancer
AU2001237414A1 (en) Cancer treatment and prognosis
AU2002324724A1 (en) Compositions and methods for the treatment of cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040308

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20060120

17Q First examination report despatched

Effective date: 20060724

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090301